SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Leifras Co., Ltd. Engages in sport training, event and alliance & club activity support and healthcare activities. It provides services related to the organization and operations of sports schools and sports events for children and it also operate a robust social business sector, dispatching sports coaches to meet various community needs. The company was founded by Kiyotaka Ito on August 28, 2001 and is headquartered in Tokyo, Japan.

Leifras Co Ltd - ADR

LEIFRAS Co., Ltd. American Depositary Shares

Shares of LFS are surging, driven by excitement around its low float and potential for a short squeeze, reminiscent of other recent IPOs. Community members are actively discussing price targets and potential sympathy plays among Japanese stocks. Some traders caution about the risks associated with pump-and-dump schemes and recent IPOs, while others highlight positive financials and growth potential.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo's stock is trending amid discussions about its valuation and future prospects following recent earnings, despite a lack of current revenue. Community chatter focuses on the company's long-term potential in the nuclear energy sector, partnerships, and concerns about insider selling. Some traders are closely watching technical indicators, like a head and shoulders pattern, while others express skepticism about the company's high market cap relative to its current stage.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

AVXL is trending as investors closely monitor the upcoming CHMP meeting, where Anavex will present on its Alzheimer's drug, Blarcamesine. Community discussions revolve around the potential outcomes, ranging from conditional approval to rejection, and the implications for short sellers who have heavily bet against the stock. Despite some concern over a required oral explanation, many remain optimistic about the drug's prospects and its potential impact on the treatment landscape.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle's stock is trending as investors anticipate upcoming earnings and a potential banking license decision. Bullish sentiment is fueled by unusual call option activity, with some speculating on a significant price increase. Community members are closely watching for a breakout and discussing potential catalysts, including the expansion of USDC and broader integration of stablecoins.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPEV is trending due to positive sentiment surrounding its expansion into new European markets and recent AI and robotics developments. Community members are discussing the potential for significant growth and profitability, drawing comparisons to Tesla's early stages. Bullish investors are pointing to the company's innovation in AI and robotics and strong revenue growth as reasons for optimism.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as hedge funds accumulate shares and unusual call option activity suggests a potential price surge. Community members are actively discussing the company's dividend yield, potential acquisition catalyst, and undervaluation compared to peers. Bullish investors believe the stock could easily reach $30 soon, citing positive accumulation and strong call option hedging activity.

Core Scientific, Inc. engages in the business of operating a purpose-built facility for digital asset mining and provision of blockchain infrastructure, software solutions, and services. It operates under the Mining and Hosting segments. The Mining segment focuses on bitcoin mining for the company's own account. The Hosting segment includes blockchain infrastructure and third-party hosting business. The company was founded by Michael Jeffrey Levitt and Darin Feinstein on December 13, 2017 and is headquartered in Dover, DE.

Core Scientific Inc - Ordinary Shares - New

Core Scientific Inc

Core Scientific ($CORZ) is trending as investors discuss the upcoming shareholder vote on the CoreWeave merger, with community sentiment divided between those favoring the deal and those believing $CORZ is worth more as a standalone AI infrastructure play. Some anticipate a potential re-rating and new customer announcements if the merger is rejected, while others worry about the company's future without the deal.

enGene Holdings, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs. The company was founded by Anthony T. Cheung on April 24, 2023 and is headquartered in Saint-Laurent, Canada.

enGene Holdings Inc

ENGN is trending due to positive Phase 2 bladder-cancer results, showcasing a 62% complete response rate and strong biotech momentum, sparking significant community discussion. Community members are actively discussing potential price targets and short squeeze opportunities. The stock's high trading volume, dramatically exceeding its average, further fuels the conversation.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.

Galecto Inc

GLTO is trending due to a recent acquisition announcement, sparking significant interest and a massive price surge. The community is actively discussing the potential for a short squeeze, given the stock's low float and high short interest, with some speculating about further gains. Trading volume is exceptionally high as the stock experiences increased volatility.

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Biohaven Ltd

Biohaven Pharmaceutical Holding Company Ltd

Biohaven is trending due to anticipation surrounding the potential FDA approval of troriluzole for spinocerebellar ataxia (SCA), with the decision expected sometime in Q4 2025. Community discussions revolve around the likelihood of approval given the absence of an advisory committee meeting, the company's strong pipeline, and its cash runway. Recent stock performance has been volatile amid broader concerns about the biotech sector and specific competitor news.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
